OncLive®, the leading resource for oncology professionals, today formally announced the beta release of Scout, an artificial intelligence-powered assistant developed to streamline access to expert clinical insight and research-based commentary. Scout is accessible on both the desktop and mobile versions of OncLive.com.
First introduced in March as a beta tool, Scout is designed to support oncology clinicians by delivering concise, contextually relevant answers derived from a trusted set of oncology news, research, and multimedia programming. The AI model is trained on an extensive library of expert-driven video discussions from OncLive’s signature programs, including Peer Exchange and Insights, to deliver results that are accurate, timely, and rooted in expert opinion.
Scout offers a practical and time-saving utility by synthesizing complex clinical discussions into succinct responses grounded in expert consensus. Each result includes direct reference links and navigational tools that allow users to view the exact segment within a video where a cited opinion or insight was delivered, eliminating the need for manual searching.
“Scout was created with the goal of enhancing clinical efficiency by enabling physicians to access high-quality, peer-informed content in real time,” said Robert Goldsmith, senior vice president of oncology corporate development at MJH Life Sciences®. “By leveraging OncLive’s deep content repository and integrating it with advanced AI capabilities, Scout represents an evolution in how oncology professionals interact with medical information by delivering relevant, expert-based guidance within seconds.”
Designed to fit seamlessly into an oncologist’s workflow, Scout provides:
- Succinct summaries based on expert video commentary and published articles.
- Quick-reference links to related reading and supporting resources.
- Direct video navigation to the exact moment an expert delivers their commentary.
- Mobile-responsive functionality, optimized for use on the go.
Scout remains in beta as ongoing development and refinement continue in partnership with the oncology community. The platform is actively gathering user feedback to inform enhancements and future iterations. A mobile application is currently in development and is anticipated to be released later this year. Scout is available now on OncLive.com via desktop and mobile browsers.
For more information or to try Scout, visit www.OncLive.com and click the Scout icon in the navigation bar.